郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Detailed In Vitro Pharmacological Characterization of the Clinically Viable Nociceptin/Orphanin FQ Peptide Receptor Antagonist BTRX-246040.

期刊：The Journal of pharmacology and experimental therapeutics发表年份：2020作者：Federica Ferrari; Sabrina Rizzo; Chiara Ruzza; Girolamo Calo
阅读更多 →

药效评价Quinazoline and phthalazine derivatives as novel melatonin receptor ligands analogues of agomelatine.

期刊：European journal of medicinal chemistry发表年份：2020作者：Raphaël Bolteau; Florian Descamps; Mohamed Ettaoussi; Daniel H Caignard; Philippe Delagrange; Patricia Melnyk; Saïd Yous
阅读更多 →

药效评价Targeting intracellular Leishmania (L.) infantum with nitazoxanide entrapped into phosphatidylserine-nanoliposomes: An experimental study.

期刊：Chemico-biological interactions发表年份：2020作者：Erika Gracielle Pinto; Leandro R S Barbosa; Renato A Mortara; Andre Gustavo Tempone
阅读更多 →

药效评价Sensitive, Rapid, Robust, and Reproducible Workflow for Host Cell Protein Profiling in Biopharmaceutical Process Development.

期刊：Journal of proteome research发表年份：2020作者：Jiao Ma; Greg W Kilby
阅读更多 →